RPL3 and cancer: Overall, our data led usto propose a working model of uL3-baseddrug resistance in which the failure of 5-FU treatment of resistantcells, silenced for uL3, is mainly due to the overexpression of specificABC transporters that pump the 5-FU outside of cancer cells, makingit ineffective (Figure 6a).